In re: Volkswagen Group of America, Inc. and In re: Hyundai Motor America, Appeal Nos. 2022-108, -109 (Fed. Cir. Mar. 9, 2022) -
In the most recent of multiple mandamus rulings issued by the Federal Circuit in relation to...more
3/15/2022
/ Appeals ,
Claim Construction ,
Dismissals ,
Improper Venue ,
Inter Partes Review (IPR) Proceeding ,
Obviousness ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patent-Eligible Subject Matter ,
Patents ,
Vacated ,
Venue ,
Writ of Mandamus ,
Written Descriptions
Adapt Pharma Operations Limited v. Teva Pharmaceuticals USA, Inc., Appeal No. 2020-2106 (Fed. Cir. Feb. 10, 2022) -
In our Case of the Week, the Court of Appeals for the Federal Circuit, in both the majority opinion and...more
2/15/2022
/ Appeals ,
En Banc Review ,
Inter Partes Review (IPR) Proceeding ,
IP License ,
Motion To Seal ,
Obviousness ,
Patent Infringement ,
Patent Invalidity ,
Patent Litigation ,
Patent-Eligible Subject Matter ,
Patents ,
Pharmaceutical Patents ,
Preliminary Injunctions ,
Prior Art ,
Remand ,
Third-Party ,
Vacated
Intel Corp. v. Qualcomm Inc., Appeal Nos. 2020-1828, -1867 (Fed. Cir. Dec. 28, 2021) -
The Federal Circuit issued two precedential decisions this week—both arising from IPRs filed by Intel against patents owned by...more
1/4/2022
/ Appeals ,
Claim Construction ,
Constitutional Challenges ,
Inter Partes Review (IPR) Proceeding ,
Means-Plus-Function ,
Obviousness ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Patents ,
Prior Art ,
Standing
AstraZeneca AB v. Mylan Pharmaceuticals Inc., Appeal No. 2021-1729 (Fed. Cir. Dec. 8, 2021) -
Our Case of the Week again focuses on numerical values in claims. Last week we addressed a case involving whether there was...more
Biogen International GMBH v. Mylan Pharmaceuticals Inc., Appeal No. 2020-1933 (Fed. Cir. Nov. 30, 2021) -
For the second time in two weeks, our Case of the Week focuses on the written description requirement, in...more
University of Strathclyde v. Clear-Vu Lighting LLC, Appeal No. 2021-2243 (Fed. Cir. Nov. 4, 2021) -
In this week’s Case of the Week, the Federal Circuit reversed an inter partes review decision finding claims directed to...more
11/9/2021
/ Abbreviated New Drug Application (ANDA) ,
Appeals ,
Dismissals ,
Improper Venue ,
Inter Partes Review (IPR) Proceeding ,
Obviousness ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Pharmaceutical Patents ,
Prior Art
Teva Pharms. Int’l GmbH v. Eli Lilly and Co., Appeal Nos. 2020-1747, -1748, -1750 (Fed. Cir. Aug. 16, 2021) -
Eli Lilly and Co. v. Teva Pharms. Int’l GmbH, Appeal Nos. 2020-1876, -1877, -1878 (Fed. Cir. Aug. 16, 2021)...more
Chemours Company FC, LLC v. Daikin Industries, Ltd., Appeal Nos. 2020-1289, -1290 (Fed. Cir. July 22, 2021) -
In this week’s Case of the Week, the Federal Circuit reversed a PTAB decision in consolidated IPRs that two...more
Raytheon Techs. Corp. v. General Elec. Co., Appeal No. 2020-1755 (Fed. Cir. Apr. 16, 2021) -
In its only precedential patent decision this week, the Federal Circuit issued an important ruling about the issue of enablement...more
In only its third precedential patent case of 2021, the Federal Circuit addressed two discrete issues. It established further precedent concerning whether references on web pages and as part of meetings of interested artisans...more
General Electric Co. v. Raytheon Techs. Corp., Appeal No. 2019-1319 (Fed. Cir. Dec. 23, 2020) -
In one of two precedential opinions this week, the Federal Circuit established new precedent concerning what it takes for a...more
C.R. Bard Inc. v. AngioDynamics, Inc., Appeal No. 2019-1756, -1934 (Fed. Cir. Nov. 10, 2020) -
Our Case of the Week is one of two cases decided this week in which the Federal Circuit finds that a district court jumped the...more
11/17/2020
/ Appeals ,
Appellate Courts ,
Claim Construction ,
Discovery ,
Dismissals ,
Equitable Estoppel ,
Genuine Issue of Material Fact ,
Inter Partes Review (IPR) Proceeding ,
Inventors ,
Obviousness ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Petition for Writ of Certiorari ,
Pharmaceutical Patents ,
Summary Judgment
PATENT CASE OF THE WEEK -
Apple Inc. v. Voip-Pal.com, Inc., Appeal No. 2018-1456, -1457 (Fed. Cir. Sept. 25, 2020) -
In our Case of the Week, the Federal Circuit addressed two novel issues following inter partes review...more
9/29/2020
/ 35 U.S.C. § 315(c) ,
Appeals ,
Apple ,
Estoppel ,
Hewlett-Packard ,
Inter Partes Review (IPR) Proceeding ,
Noninfringement ,
Obviousness ,
Patent Infringement ,
Patent Invalidity ,
Patent Litigation ,
Patents ,
Summary Judgment ,
Twitter
PATENT CASE OF THE WEEK -
American Axle & Manufacturing, Inc. v. Neapco Holdings LLC, Appeal No. 2018-1763 (Fed. Cir. July 31, 2020) -
In this week’s Case of the Week, the Federal Circuit modified and re-issued its...more
8/4/2020
/ Alice/Mayo ,
Appeals ,
Intellectual Property Owners Association ,
Inter Partes Review (IPR) Proceeding ,
Obviousness ,
Patent Invalidity ,
Patent Trial and Appeal Board ,
Patent-Eligible Subject Matter ,
Patents ,
Section 101 ,
Substantial Evidence Standard ,
Summary Judgment
PATENT CASE OF THE WEEK -
Uniloc 2017 LLC v. Apple, Inc., Appeal Nos. 2019-1922, -1923, -1925, -1926 (Fed. Cir. July 9, 2020) -
This week’s case of the week focuses, not on a patent issue, but on a procedural issue common...more
7/14/2020
/ Appeals ,
Apple ,
Confidential Information ,
Inter Partes Review (IPR) Proceeding ,
License Agreements ,
Litigation Strategies ,
Motion to Dismiss ,
Motion To Seal ,
Obviousness ,
Patent Infringement ,
Patent Trial and Appeal Board ,
Public Records ,
Third-Party
This week’s case of the week deals with issues relating to obviousness and standing in a consolidated appeal of two final written decisions issued in inter partes review (“IPR”) proceedings before the Patent Trial and Appeal...more
PATENT CASE OF THE WEEK -
Samsung Electronics America, Inc. v. Prisua Engineering Corp., Appeal No. 2019-1169, -1260 (Fed. Cir. Feb. 4, 2020) -
Our case of the week concerns issues particular to inter partes review...more
2/11/2020
/ America Invents Act ,
Appeals ,
Apple ,
Indefiniteness ,
Inter Partes Review (IPR) Proceeding ,
Internet Streaming ,
IP License ,
License Agreements ,
Obviousness ,
Patent Infringement ,
Patent Invalidity ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Prior Art ,
Remand ,
Samsung ,
Settlement ,
Summary Judgment ,
Testimony
PATENT CASE OF THE WEEK -
Koninklijke Philips N.V. v. Google LLC, et al., Appeal No. 2019-1177 (Fed. Cir. Jan. 30, 2020) -
In the Federal Circuit’s only precedential decision this week, the Court affirmed a PTAB finding...more
PATENT CASE OF THE WEEK -
Eko Brands, LLC v. Adrian Rivera Maynez Enterprises, Inc., Appeal Nos. 2018-2215, et al. (Fed. Cir. Jan. 13, 2020) -
In this appeal from the Western District of Washington, the Federal Circuit...more
1/22/2020
/ Appeals ,
Attorney's Fees ,
Claim Construction ,
Compensatory Damages ,
Enhanced Damages ,
Jury Instructions ,
Jury Trial ,
Motion for Summary Judgment ,
Noninfringement ,
Obviousness ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Willful Infringement
PATENT CASE OF THE WEEK -
Amgen Inc. v. Amneal Pharmaceuticals LLC, et al., Appeal Nos. 2018-2414, et al. (Fed. Cir. Jan. 7, 2020) -
In this appeal from Markman and summary judgment opinions by the district court in a...more
1/14/2020
/ Abbreviated New Drug Application (ANDA) ,
America Invents Act ,
Amgen ,
Claim Construction ,
Hatch-Waxman ,
Intellectual Property Protection ,
Inter Partes Review (IPR) Proceeding ,
Obviousness ,
Patent Infringement ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
POSITA ,
Prior Art
PATENT CASE OF THE WEEK -
Persion Pharms. LLC v. Alvogen Malta Operations Ltd., Appeal No. 2018-2361 (Fed. Cir. Dec. 27, 2019) -
In this week’s Case of the Week, the Federal Circuit affirmed a district court judgment...more
12/31/2019
/ Appeals ,
Evidence ,
Food and Drug Administration (FDA) ,
Obviousness ,
Patent Invalidity ,
Patent Litigation ,
Patents ,
Pharmaceutical Patents ,
POSITA ,
Prior Art ,
Reaffirmation
PATENT CASE OF THE WEEK -
Columbia Sportswear North America, Inc. v. Seirus Innovative Accessories, Inc., Appeal Nos. 2018-1329, et al. (Fed. Cir. Nov. 13, 2019) -
This week’s Case of the Week strikes close to home,...more
11/19/2019
/ Abstract Ideas ,
Design Patent ,
Intellectual Property Litigation ,
Intellectual Property Protection ,
Obviousness ,
Patent Infringement ,
Patent Litigation ,
Patent-Eligible Subject Matter ,
Patents ,
Prior Art ,
Section 101 ,
Venue
PATENT CASE OF THE WEEK -
SIPCO, LLC v. Emerson Electric Co., Appeal No. 2018-1635 (Fed. Cir. Sept. 25, 2019) -
In this appeal of the Patent Trial and Appeal Board’s (PTAB) final written decision regarding covered...more
10/1/2019
/ America Invents Act ,
Campbell Soup Company ,
Claim Construction ,
Covered Business Method Patents ,
Covered Business Method Proceedings ,
Design Patent ,
Obviousness ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Prior Art ,
Remand ,
Section 103 ,
Vacated
Curver Luxembourg, SARL v. Home Expressions Inc., Appeal No. 2018-2214 (Fed. Cir. Sept. 12, 2019)
In a significant case in the field of design patents, the Federal Circuit clarified the scope of design patent infringement...more
9/17/2019
/ Acquisitions ,
Antitrust Violations ,
Appeals ,
Collateral Estoppel ,
Counterclaims ,
Design Patent ,
Intellectual Property Litigation ,
Intellectual Property Protection ,
Inter Partes Review (IPR) Proceeding ,
Monopolization ,
Obviousness ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Prior Art ,
Sherman Act ,
Summary Judgment ,
The Clayton Act
Arthrex, Inc. v. Smith & Nephew, Inc., Appeal No. 2018-1584 (Fed. Cir. Aug. 21, 2019) -
In this week’s Case of the Week, the Federal Circuit affirmed an inter partes review decision of the Patent Trial and Appeal Board,...more
8/27/2019
/ Administrative Procedure Act ,
Claim Construction ,
Enhanced Damages ,
Evidence ,
Inter Partes Review (IPR) Proceeding ,
Inventive Concept Test ,
Motivation to Combine ,
Obviousness ,
Patent Invalidity ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patent-Eligible Subject Matter ,
Patents ,
Prior Art ,
Reversal ,
Vacated